These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25311350)

  • 21. Symposium on immunotherapy in malignant disease. Foreward.
    Terry WD
    Med Clin North Am; 1976 May; 60(3):387-8. PubMed ID: 1271885
    [No Abstract]   [Full Text] [Related]  

  • 22. The case for cancer immunotherapy.
    Liu K
    Drug Discov Today; 2003 Jun; 8(12):530-1. PubMed ID: 12821297
    [No Abstract]   [Full Text] [Related]  

  • 23. Combining radiotherapy with immunotherapy: the past, the present and the future.
    Van Limbergen EJ; De Ruysscher DK; Olivo Pimentel V; Marcus D; Berbee M; Hoeben A; Rekers N; Theys J; Yaromina A; Dubois LJ; Lambin P
    Br J Radiol; 2017 Aug; 90(1076):20170157. PubMed ID: 28541096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview: immunotherapy for cancer--is it time for the kitchen sink?
    Davis TA
    Curr Opin Investig Drugs; 2002 Jan; 3(1):130-1. PubMed ID: 12054063
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid Advances in Immunotherapy to Treat Cancer.
    McCune JS
    Clin Pharmacol Ther; 2018 Apr; 103(4):540-544. PubMed ID: 29527663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Immunotherapy of cancer: present status and future promise": Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd-25th September 2013.
    Donia M; Lyngaa R; Hadrup SR
    Cancer Immunol Immunother; 2014 Sep; 63(9):985-9. PubMed ID: 25056819
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunotherapy transforms cancer treatment.
    Zaidi N; Jaffee EM
    J Clin Invest; 2019 Jan; 129(1):46-47. PubMed ID: 30507614
    [No Abstract]   [Full Text] [Related]  

  • 28. [Problems of tumor immunity and the possibility of immunotherapy in tumor].
    Shimoyama M
    Nihon Rinsho; 1971; 29(6):1515-29. PubMed ID: 4933610
    [No Abstract]   [Full Text] [Related]  

  • 29. Host immunity ignored in clinical oncology: a medical opinion.
    Elliott RL; Head JF
    Cancer Biother Radiopharm; 2005 Apr; 20(2):123-5. PubMed ID: 15869445
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer vaccines: pessimism in check.
    Mocellin S; Mandruzzato S; Bronte V; Marincola FM
    Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunology and immunotherapy of malignant neoplasms and blood diseases].
    Papaleo G; Zito GA; Giordano G
    Recenti Prog Med; 1978 Mar; 64(3):310-53. PubMed ID: 351752
    [No Abstract]   [Full Text] [Related]  

  • 32. First conference on cancer immunotherapy gets "explosion of interest".
    Hawkes N
    BMJ; 2015 Sep; 351():h4876. PubMed ID: 26362316
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunotherapy of neoplasms with special consideration of leukemia].
    Kotlarek-Haus S
    Pol Arch Med Wewn; 1979 Aug; 62(2):127-35. PubMed ID: 503893
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer immunotherapy: harnessing the immune system to battle cancer.
    Yang Y
    J Clin Invest; 2015 Sep; 125(9):3335-7. PubMed ID: 26325031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer immunotherapy in 2017: The breakthrough of the microbiota.
    Kroemer G; Zitvogel L
    Nat Rev Immunol; 2018 Jan; 18(2):87-88. PubMed ID: 29379189
    [No Abstract]   [Full Text] [Related]  

  • 36. Short review. Prospects for cancer immunochemotherapy.
    Rubens RD
    Cancer Treat Rev; 1974 Dec; 1(4):305-12. PubMed ID: 4219751
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of immunotherapy in oncology.
    Riccio V; Carrano S; Buonerba C; Di Lorenzo G
    Future Oncol; 2015; 11(21):2861-4. PubMed ID: 26404049
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapy in acute leukemia.
    Leung W
    Semin Hematol; 2009 Jan; 46(1):89-99. PubMed ID: 19100371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Unleashing NK cell signaling to improve cancer immunotherapy].
    Bernard PL; Laletin V; Pastor S; Nunès JA; Guittard G
    Med Sci (Paris); 2020 Oct; 36 Hors série n° 1():50-55. PubMed ID: 33052095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.